<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
Carrington Laboratories, Inc.
- --------------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
2001 Walnut Hill Lane, Irving, TX 75038
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (214) 518-1300
---------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding.
1. Title of security Common Stock, $.01 par value
----------------------------------------------------------
2. Number of shares outstanding before the change 8,269,937
-----------------------------
3. Number of shares outstanding after the change 8,729,302
------------------------------
4. Effective date of change February 29, 1996
---------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
Issuance of (i) a total of 237,731 shares upon exercise of outstanding stock
- --------------------------------------------------------------------------------
options, (ii) 174,935 shares upon the conversion of all shares of Cumulative
- --------------------------------------------------------------------------------
Convertible Preferred Stock, (iii) 36,250 shares upon exercise of outstanding
- --------------------------------------------------------------------------------
warrants, and (iv) 10,449 shares issued through the Employees Stock Purchase
- --------------------------------------------------------------------------------
Plan.
- --------------------------------------------------------------------------------
Give brief description of transaction (see above)
-----------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
-------------------------------------------------------
2. Name after change
---------------------------------------------------------
3. Effective date of charter amendment changing name
---------------------------
4. Date of shareholder approval of change, if required
------------------------
Carlton E. Turner
Date April 16, 1996 President and Chief Executive Officer
-------------------- -------------------------------------------
(Officer's signature & title)
